Rubraca 250 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FCL3A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,919
Award facts
- Contract value 100% obligated
- $16,918.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Rubraca 250 mg tablets (60-count) with a ceiling value of $16,918.74. This firm fixed price delivery order is scheduled for completion by November 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive, competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle valued through December 2026 that enables the contractor to supply medications and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal medical contracts predominantly with the Defense Logistics Agency. As a critical vendor for military and veteran healthcare systems, the company supplies a broad range of pharmaceutical products including brand-name and generic medications, specialty treatments, and medical devices across multiple therapeutic domains. This delivery order for Rubraca, an oncology medication, reflects the company's ongoing role in supporting the Defense Health Agency and other government healthcare systems through flexible contract vehicles that allow responsive procurement of pharmaceutical commodities to meet military medical requirements.
Quick answers
Who was awarded contract SPE2DR26FCL3A?
SPE2DR26FCL3A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DR26FCL3A worth?
The government has obligated $16,919 on SPE2DR26FCL3A.
Is contract SPE2DR26FCL3A an order under another contract?
Yes. SPE2DR26FCL3A is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCL3A competed?
The extent of competition for SPE2DR26FCL3A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award